Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 134

1.

Active cytomegalovirus retinitis after the start of antiretroviral therapy.

Heiden D, Tun N, Smithuis FN, Keenan JD, Oldenburg CE, Holland GN, Drew WL.

Br J Ophthalmol. 2019 Feb;103(2):157-160. doi: 10.1136/bjophthalmol-2018-312406. Epub 2018 Sep 8.

PMID:
30196272
2.

Mortality in patients with AIDS-related cytomegalovirus retinitis in Myanmar.

Tun N, Smithuis FM, London N, Drew WL, Heiden D.

Clin Infect Dis. 2014 Dec 1;59(11):1650-1. doi: 10.1093/cid/ciu648. Epub 2014 Aug 13. No abstract available.

3.

We urge WHO to act on cytomegalovirus retinitis.

Heiden D, Saranchuk P, Tun N, Audoin B, Cohn J, Durier N, Holland G, Drew WL, 't Hoen E.

Lancet Glob Health. 2014 Feb;2(2):e76-7. doi: 10.1016/S2214-109X(13)70174-8. Epub 2014 Jan 23. No abstract available.

4.

Repopulation of ganciclovir-resistant cytomegalovirus by wild-type virus.

Drew WL, Liu C.

Clin Transplant. 2012 Nov-Dec;26(6):949-52. doi: 10.1111/j.1399-0012.2012.01681.x. Epub 2012 Jul 9.

PMID:
22774759
5.

CMV retinitis screening and treatment in a resource-poor setting: three-year experience from a primary care HIV/AIDS programme in Myanmar.

Tun N, London N, Kyaw MK, Smithuis F, Ford N, Margolis T, Drew WL, Lewallen S, Heiden D.

J Int AIDS Soc. 2011 Aug 15;14:41. doi: 10.1186/1758-2652-14-41.

6.

Pandemic (H1N1) 2009 infection in patients with hematologic malignancy.

Liu C, Schwartz BS, Vallabhaneni S, Nixon M, Chin-Hong PV, Miller SA, Chiu C, Damon L, Drew WL.

Emerg Infect Dis. 2010 Dec;16(12):1910-7. doi: 10.3201/eid1612.100772.

7.

Cytomegalovirus resistance testing: pitfalls and problems for the clinician.

Drew WL.

Clin Infect Dis. 2010 Mar 1;50(5):733-6. doi: 10.1086/650463. Review.

PMID:
20100090
8.

Highly quantitative serological detection of anti-cytomegalovirus (CMV) antibodies.

Burbelo PD, Issa AT, Ching KH, Exner M, Drew WL, Alter HJ, Iadarola MJ.

Virol J. 2009 May 1;6:45. doi: 10.1186/1743-422X-6-45.

9.

Valacyclovir to reduce transmission of genital herpes simplex virus infection.

Drew WL.

J Infect Dis. 2009 Mar 15;199(6):916. doi: 10.1086/597068. No abstract available.

PMID:
19239344
10.

Utility of DNA microarrays for detection of viruses in acute respiratory tract infections in children.

Chiu CY, Urisman A, Greenhow TL, Rouskin S, Yagi S, Schnurr D, Wright C, Drew WL, Wang D, Weintrub PS, Derisi JL, Ganem D.

J Pediatr. 2008 Jul;153(1):76-83. doi: 10.1016/j.jpeds.2007.12.035. Epub 2008 Mar 7.

11.

Cytomegalovirus retinitis: the neglected disease of the AIDS pandemic.

Heiden D, Ford N, Wilson D, Rodriguez WR, Margolis T, Janssens B, Bedelu M, Tun N, Goemaere E, Saranchuk P, Sabapathy K, Smithuis F, Luyirika E, Drew WL.

PLoS Med. 2007 Dec;4(12):e334. No abstract available.

12.

Prevention of transfusion-transmitted cytomegalovirus: reactivation of the debate?

Drew WL, Roback JD.

Transfusion. 2007 Nov;47(11):1955-8. Review. No abstract available.

PMID:
17958521
13.

Laboratory diagnosis of cytomegalovirus infection and disease in immunocompromised patients.

Drew WL.

Curr Opin Infect Dis. 2007 Aug;20(4):408-11. Review.

PMID:
17609601
14.

Development of new cytomegalovirus UL97 and DNA polymerase mutations conferring drug resistance after valganciclovir therapy in allogeneic stem cell recipients.

Marfori JE, Exner MM, Marousek GI, Chou S, Drew WL.

J Clin Virol. 2007 Feb;38(2):120-5. Epub 2006 Dec 8.

PMID:
17157554
15.

Maribavir sensitivity of cytomegalovirus isolates resistant to ganciclovir, cidofovir or foscarnet.

Drew WL, Miner RC, Marousek GI, Chou S.

J Clin Virol. 2006 Oct;37(2):124-7. Epub 2006 Sep 8.

PMID:
16962820
16.

Is combination antiviral therapy for CMV superior to monotherapy?

Drew WL.

J Clin Virol. 2006 Apr;35(4):485-8. Epub 2006 Jan 18. Review.

PMID:
16387546
17.

The role of photochemical treatment with amotosalen and UV-A light in the prevention of transfusion-transmitted cytomegalovirus infections.

Roback JD, Conlan M, Drew WL, Ljungman P, Nichols WG, Preiksaitis JK.

Transfus Med Rev. 2006 Jan;20(1):45-56. Review.

PMID:
16373187
18.

Performance characteristics of clinical diagnosis, a clinical decision rule, and a rapid influenza test in the detection of influenza infection in a community sample of adults.

Stein J, Louie J, Flanders S, Maselli J, Hacker JK, Drew WL, Gonzales R.

Ann Emerg Med. 2005 Nov;46(5):412-9. Epub 2005 Aug 15.

PMID:
16271670
19.

Characterization of viral agents causing acute respiratory infection in a San Francisco University Medical Center Clinic during the influenza season.

Louie JK, Hacker JK, Gonzales R, Mark J, Maselli JH, Yagi S, Drew WL.

Clin Infect Dis. 2005 Sep 15;41(6):822-8. Epub 2005 Aug 4.

PMID:
16107980
20.

I wish to comment on several points in the recent "Guidelines".

Drew WL.

J Clin Virol. 2005 May;33(1):79. No abstract available.

PMID:
15797370
21.

Performance of a bedside C-reactive protein test in the diagnosis of community-acquired pneumonia in adults with acute cough.

Flanders SA, Stein J, Shochat G, Sellers K, Holland M, Maselli J, Drew WL, Reingold AL, Gonzales R.

Am J Med. 2004 Apr 15;116(8):529-35.

PMID:
15063814
22.

Emergence of drug-resistant cytomegalovirus retinitis in the contralateral eyes of patients with AIDS treated with ganciclovir.

Imai Y, Shum C, Martin DF, Kuppermann BD, Drew WL, Margolis TP.

J Infect Dis. 2004 Feb 15;189(4):611-5. Epub 2004 Jan 28.

PMID:
14767813
23.

Absence of activation of CMV by blood transfusion to HIV-infected, CMV-seropositive patients.

Drew WL, Chou S, Mohr BA, Assmann SF, Miner RC, Laycock ME, Busch MP; Viral Activation Transfusion Study Group.

Transfusion. 2003 Oct;43(10):1351-7.

PMID:
14507264
24.

Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus.

Chou S, Lurain NS, Thompson KD, Miner RC, Drew WL.

J Infect Dis. 2003 Jul 1;188(1):32-9. Epub 2003 Jun 16. Erratum in: J Infect Dis. 2004 Sep 15;190(6):1202.

PMID:
12825168
25.

Cytomegalovirus Disease in the Highly Active Antiretroviral Therapy Era.

Drew WL.

Curr Infect Dis Rep. 2003 Jun;5(3):257-265.

PMID:
12760824
26.

CMV DNA is rarely detected in healthy blood donors using validated PCR assays.

Roback JD, Drew WL, Laycock ME, Todd D, Hillyer CD, Busch MP.

Transfusion. 2003 Mar;43(3):314-21.

PMID:
12675715
27.

Frequency and duration of plasma CMV viremia in seroconverting blood donors and recipients.

Drew WL, Tegtmeier G, Alter HJ, Laycock ME, Miner RC, Busch MP.

Transfusion. 2003 Mar;43(3):309-13.

PMID:
12675714
28.

Phase I dose escalation trial evaluating the pharmacokinetics, anti-human cytomegalovirus (HCMV) activity, and safety of 1263W94 in human immunodeficiency virus-infected men with asymptomatic HCMV shedding.

Lalezari JP, Aberg JA, Wang LH, Wire MB, Miner R, Snowden W, Talarico CL, Shaw S, Jacobson MA, Drew WL.

Antimicrob Agents Chemother. 2002 Sep;46(9):2969-76.

29.

Cytomegalovirus (CMV) resistance to antivirals.

Drew WL, Paya CV, Emery V.

Am J Transplant. 2001 Nov;1(4):307-12. Review.

30.

Cytomegalovirus glycoprotein B groups in human immunodeficiency virus-infected patients with incident retinitis.

Drew WL, Chou S, Miner RC, Mohr BA, Busch MP, van der Horst CM, Asmuth DM, Kalish LA.

J Infect Dis. 2002 Jul 1;186(1):114-7. Epub 2002 May 22.

PMID:
12089671
31.

Cytomegalovirus UL97 phosphotransferase mutations that affect susceptibility to ganciclovir.

Chou S, Waldemer RH, Senters AE, Michels KS, Kemble GW, Miner RC, Drew WL.

J Infect Dis. 2002 Jan 15;185(2):162-9. Epub 2001 Dec 17.

PMID:
11807689
32.

High dose oral ganciclovir treatment for cytomegalovirus retinitis.

Lalezari JP, Friedberg DN, Bissett J, Giordano MF, Hardy WD, Drew WL, Hubbard LD, Buhles WC, Stempien MJ, Georgiou P, Jung DT, Robinson CA; Roche Cooperative Oral Ganciclovir Study Group.

J Clin Virol. 2002 Feb;24(1-2):67-77.

PMID:
11744430
33.

Multicenter evaluation of PCR methods for detecting CMV DNA in blood donors.

Roback JD, Hillyer CD, Drew WL, Laycock ME, Luka J, Mocarski ES, Slobedman B, Smith JW, Soderberg-Naucler C, Todd DS, Woxenius S, Busch MP.

Transfusion. 2001 Oct;41(10):1249-57.

PMID:
11606824
34.

Variations in the cytomegalovirus DNA polymerase and phosphotransferase genes in relation to foscarnet and ganciclovir sensitivity.

Mousavi-Jazi M, Schloss L, Drew WL, Linde A, Miner RC, Harmenberg J, Wahren B, Brytting M.

J Clin Virol. 2001 Dec;23(1-2):1-15.

PMID:
11595579
35.

Antiviral activity and ocular kinetics of antisense oligonucleotides designed to inhibit CMV replication.

Henry SP, Miner RC, Drew WL, Fitchett J, York-Defalco C, Rapp LM, Levin AA.

Invest Ophthalmol Vis Sci. 2001 Oct;42(11):2646-51.

PMID:
11581212
36.

Correlates of change in cytomegalovirus viremia in patients with advanced human immunodeficiency virus infection who require transfusion.

Para MF, Kalish LA, Collier AC, Murphy EL, Drew WL; Viral Activation Transfusion Study Group.

J Infect Dis. 2001 Jun 1;183(11):1673-7. Epub 2001 Apr 27.

PMID:
11343218
37.

Qualitative and quantitative PCR measures of cytomegalovirus in patients with advanced HIV infection who require transfusions.

Para MF, Kalish LA, Collier AC, Pollard RB, Kumar PN, Mintz L, Wallach FR, Drew WL; Viral Activation Transfusion Study (VATS) Group.

J Acquir Immune Defic Syndr. 2001 Apr 1;26(4):320-5.

PMID:
11317072
38.
39.

A deletion mutation in region V of the cytomegalovirus DNA polymerase sequence confers multidrug resistance.

Chou S, Miner RC, Drew WL.

J Infect Dis. 2000 Dec;182(6):1765-8. Epub 2000 Oct 17.

PMID:
11069251
40.

Ganciclovir resistance: a matter of time and titre.

Drew WL.

Lancet. 2000 Aug 19;356(9230):609-10. No abstract available.

PMID:
10968428
41.

A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates.

Landry ML, Stanat S, Biron K, Brambilla D, Britt W, Jokela J, Chou S, Drew WL, Erice A, Gilliam B, Lurain N, Manischewitz J, Miner R, Nokta M, Reichelderfer P, Spector S, Weinberg A, Yen-Lieberman B, Crumpacker C.

Antimicrob Agents Chemother. 2000 Mar;44(3):688-92.

42.

Cytomegalovirus: disease syndromes and treatment.

Drew WL, Lalezari JP.

Curr Clin Top Infect Dis. 1999;19:16-29. Review. No abstract available.

PMID:
10472478
43.

Decrease of cytomegalovirus replication in human immunodeficiency virus infected-patients after treatment with highly active antiretroviral therapy.

O'Sullivan CE, Drew WL, McMullen DJ, Miner R, Lee JY, Kaslow RA, Lazar JG, Saag MS.

J Infect Dis. 1999 Sep;180(3):847-9.

PMID:
10438377
44.

Cytomegalovirus (CMV) resistance in patients with CMV retinitis and AIDS treated with oral or intravenous ganciclovir.

Drew WL, Stempien MJ, Andrews J, Shadman A, Tan SJ, Miner R, Buhles W.

J Infect Dis. 1999 Jun;179(6):1352-5.

PMID:
10228054
45.

In vitro antiviral susceptibilities of isolates from cytomegalovirus retinitis patients receiving first- or second-line cidofovir therapy: relationship to clinical outcome.

Cherrington JM, Fuller MD, Lamy PD, Miner R, Lalezari JP, Nuessle S, Drew WL.

J Infect Dis. 1998 Dec;178(6):1821-5.

PMID:
9815243
46.

Condoms and the transmission of cytomegalovirus.

Drew WL.

Sex Transm Dis. 1998 Oct;25(9):481-2. No abstract available.

PMID:
9800260
47.

Mutation in region III of the DNA polymerase gene conferring foscarnet resistance in cytomegalovirus isolates from 3 subjects receiving prolonged antiviral therapy.

Chou S, Marousek G, Parenti DM, Gordon SM, LaVoy AG, Ross JG, Miner RC, Drew WL.

J Infect Dis. 1998 Aug;178(2):526-30.

PMID:
9697736
48.

Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USA.

Whitley RJ, Jacobson MA, Friedberg DN, Holland GN, Jabs DA, Dieterich DT, Hardy WD, Polis MA, Deutsch TA, Feinberg J, Spector SA, Walmsley S, Drew WL, Powderly WG, Griffiths PD, Benson CA, Kessler HA.

Arch Intern Med. 1998 May 11;158(9):957-69.

PMID:
9588429
49.

Perspectives on switching oral acyclovir from prescription to over-the-counter status: report of a consensus panel.

Sande MA, Armstrong D, Corey L, Drew WL, Gilbert D, Moellering RC Jr, Smith LG.

Clin Infect Dis. 1998 Mar;26(3):659-63.

PMID:
9524840
50.

The safety and efficacy of adefovir dipivoxil, a novel anti-human immunodeficiency virus (HIV) therapy, in HIV-infected adults: a randomized, double-blind, placebo-controlled trial.

Deeks SG, Collier A, Lalezari J, Pavia A, Rodrigue D, Drew WL, Toole J, Jaffe HS, Mulato AS, Lamy PD, Li W, Cherrington JM, Hellmann N, Kahn J.

J Infect Dis. 1997 Dec;176(6):1517-23.

PMID:
9395363

Supplemental Content

Support Center